chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Restlessness; Insomnia; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. It was not reported if the patient had received other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced restlessness and insomnia. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events restlessness and insomnia were unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
@ 1030 had fever was given APAP & put pt to bed 12AM woke up & cried as if in pain about 1 hr; fever was 106-mom used tepid bath then took to ER; t99 p/bath; ER MD given more APAP;
Rashes, hives and total face, neck, and torso and arms completely red as the hives grow. Several episodes where it was so bad I had anaphylaxis requiring epinephrine injections with O2 sat down to 70! This went on every day for 3 1/2 weeks. I was already taking Allegra, Xzyzal, singularity, and famotidine to stabilize my mast cells. Cromolyn and Benadryl added.
02/1/06, 1 week after vaccines child broke out in blister like rash on hands, feet, mouth & legs. ED visit and treated with Benadryl and Tylenol. Fever.
2-3 days After vaccine - patched of taste buds gone, like i burned my tongue.  Went away after a week. Vision issues  - blurry vision continues Stomach pain on and off - continues
EXTREMELY ITCHY RED PATCHES ON SKIN WHICH SPREADS REALLY FAST; FEVER OVERNIGHT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 30-MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 30-MAY-2021, the patient experienced fever overnight. On an unspecified date, the patient experienced extremely itchy red patches on skin which spreads really fast. The action taken with covid-19 vaccine was not applicable. The patient recovered from fever overnight on 31-MAY-2021, and had not recovered from extremely itchy red patches on skin which spreads really fast. This report was non-serious. This case, from the same reporter is linked to 20210708299, 20210738736 and 20210442576.
Diffuse rashes all over body for past 4 days.  Started from abd & spread to entire whole body, maculopapular, erythematous, purpuric.
Information has been received from a company representative reporting an adverse event that she heard on a new station on 12-NOV-2007 concerning a 14 year old female who was vaccinated with her first dose of Gardasil by her pediatrician. On her way home she developed abdominal cramping and loss of consciousness. The patients mother contacted the pediatrician who gave them a fact sheet listing the side effects of Gardasil. The lot number was not provided and the pediatrician's name was not mentioned. No further information is available.
Ee entered observation @ 1630.  This nurse asked Ee if she was feeling okay around 1645.  Stated she felt as if she had a "lump in her throat".  Denied any type of SOB or breathing issues.  @ 1650, Ee stated she felt an itching, burning, and tingling to her lips and chin.  Ee also had mild edema noted to her lips.  Also stated that she had onset nasal congestion.  Benadryl 25mg given @ 1652.  Ee remains @ observation @ present time, 1706. @ 1715 Ee stated that she had mild itching to entire body.  Around 1720, stated that the symptoms were easing up.  @ 1725, Ee stated that the symptoms were better, but slight itching still remained.  Insisted on leaving observation, stated she was okay.  Ee left observation @ 1726.
PATIENT WAS GIVEN BOOSTER DOSE OF PFIZER APPROXIMATELY 3 MONTHS TOO SOON PER CDC GUIDELINES.
some inflammation; dizzyness; pale; was pale and weak; was trying to read on the phone and the words where waving, words where like waves in an; really painful arm; nausea; redness; swelling; This spontaneous case was reported by a physician and describes the occurrence of READING DISORDER (was trying to read on the phone and the words where waving, words where like waves in an), PAIN IN EXTREMITY (really painful arm), ERYTHEMA (redness), INFLAMMATION (some inflammation) and DIZZINESS (dizzyness) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MONTELUKAST and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced READING DISORDER (was trying to read on the phone and the words where waving, words where like waves in an), PAIN IN EXTREMITY (really painful arm), ERYTHEMA (redness), INFLAMMATION (some inflammation), PALLOR (pale), ASTHENIA (was pale and weak), SWELLING (swelling) and NAUSEA (nausea). an unknown date, the patient experienced DIZZINESS (dizzyness). At the time of the report, READING DISORDER (was trying to read on the phone and the words where waving, words where like waves in an), PAIN IN EXTREMITY (really painful arm), INFLAMMATION (some inflammation), DIZZINESS (dizzyness), PALLOR (pale) and ASTHENIA (was pale and weak) outcome was unknown and ERYTHEMA (redness), SWELLING (swelling) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Concomitant medications were added.
0n 01/29/2021, Immediately after the injection, I felt shortness of breath. It lasted for the rest of the day. I woke feeling better the next morning. They were giving it at the Fire Department, I asked the EMT about the SOB, and they said since I was talking,  they said I would be okay. I did not have the SOB with dose 1 or dose 3. Like I said, the next morning it was gone.   Around 06/2021- I was having extreme fatigue, I went to my kidney doctor. They did a panel of blood work.  The GFR showed  my kidney function dropped from 24 to 18 percent. My nephrologist recommended  I get on the kidney transplant list  at the Facility and the Facility. I am in the process, I have been accepted. There are a lot of test that need to be done.
8 Pts developed Cellulitis requiring antibiotic therapy.  At least two of these patients were treated in ER none had prior Pneumococcal vaccinations.
Five hours post vax the pt experienced itching all over. The vaccinee was treated with Benadryl. The outcome was not reported. Follow up information indicates that the symptoms resolved within 3 days.
A report was received from a health care professional on 11/21/2002 concerning  eleven vaccinees between the ages os 56-84 years who were inadvertently administered 1ml Fluvirin on an unreported date.  On an unreported date eleven vaccinees were inadvertently administered Fluvirin. No adverse reactions was reported. There was insufficient information to determine the reporters causality assessment.  Update1. 12/31/2002:  A follow up report was received form a health care professional indicated that a 65 year old male vaccinee was inadvertently administered 1.0ml Fluvirin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200904, PJP2002009003, PJP200200902, PJP200200901, PJP200200900, PJP200200900, PJP200200899, PJP200200894, PJP200200907.
Initial report was received 13 July 2009 from a consumer who is also the patient. A 52-year-old female patient had received an injection of IMOVAX Rabies (also reported as HDCV, lot number not reported) at 16:00 hours on 09 July 2009, and approximately 10 hours later, she developed a fever, generalized achiness, nausea, diarrhea, chills, a severe headache and was confused. The patient contacted a health care professional in her state, as well as the Center for Disease Control and Prevention (CDC) for guidance on completing the final dose of the post-exposure two dose series and it was recommended she complete the second dose with a chick cell culture rabies vaccine. The patient received the second dose on an unspecified date and an unspecified amount of time later, she experienced some achiness, nausea and a headache. The patient had previously received a pre-exposure series of rabies vaccine ten years ago and subsequently received a two dose post-exposure rabies vaccine series due to a "bite situation" four to five years ago. According to the patient, she had not received any other vaccines within the four weeks prior to receiving IMOVAX. At the time of the report, the patient's recovery status was reported as unknown. Follow up information received from the patient on 05 August 2009 who stated that the IMOVAX was administered in the left arm and the Rabies vaccine was administered in the right arm. No other vaccines were received within 4 weeks of 09 July 2009. The patient recovered. Follow-up information received on 24 August 2009 from a consumer. The patient had no concurrent illnesses at the time of the IMOVAX vaccination on 09 July 2009. The patient has pre-existing medical condition of hiatal hernia for which she takes Ranitidine concomitantly. Per the patient, she also experienced symptoms of achiness, nausea and headache two hours after administration of Dose #2 Rabies vaccine (manufacturer unknown) that lasted 10-12 hours. The adverse events did not require physician visit or treatment. The indication for the vaccinations was due to a non-bite, animal saliva in open cut. The animal treated positive. Follow-up information was received from a health care professional on 09 November 2009 which indicated that the patient had not received the vaccines at that facility. The health care provider had no information regarding the event.
I woke up from a dead sleep and coughed, suddenly my heart rate jumped into high gear, my heart beat was over 120 beats per minute for one hour. I had chest pain and my jaw hurt and I could not lay down because it was very comfortable for my chest and felt like there was more pressure when I laid down. I came out of it by sitting upright, breathing deeply and drinking water. It took about 2 days for my chest to feel normal again, it felt like my lungs had been really overworked, I was exhausted and I started feeling normal again about the 4th day from the event.
STOMACH BLOATING; LEG SWELLING; LEGS HURT; MUSCLE ACHES; FATIGUED; DIARRHEA; VOMITTING; SWEATING; This spontaneous report received from a patient concerned a 51 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included borderline diabetic, congestive heart failure, lung failure, and smoker, and other pre-existing medical conditions included ipratropium bromide inhaler,breo inhaler,albuterol inhaler. 2 clamps on liver. sulfate drugs, zithromax, ambien allergy. The patient experienced drug allergy when treated with zolpidem tartrate, sulfacetamide sodium/sulfadiazine/sulfadimidine/sulfamerazine, and azithromycin. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 01-JUN-2021 for prophylactic vaccination. Concomitant medications included furosemide for congestive heart failure, potassium for congestive heart failure, spironolactone for congestive heart failure, fluticasone furoate/vilanterol trifenatate for lung failure, ipratropium bromide for lung failure, and salbutamol for lung failure. On 02-JUN-2021, the subject experienced diarrhea. On 02-JUN-2021, the subject experienced vomitting. On 02-JUN-2021, the subject experienced sweating. On 02-JUN-2021, the subject experienced muscle aches. On 02-JUN-2021, the subject experienced fatigued. On 05-JUN-2021, the subject experienced stomach bloating. On 05-JUN-2021, the subject experienced leg swelling. On 05-JUN-2021, the subject experienced legs hurt. The action taken with covid-19 vaccine was not applicable. The patient recovered from diarrhea, vomitting, and sweating, was recovering from muscle aches, and fatigued, and had not recovered from leg swelling, stomach bloating, and legs hurt. This report was non-serious.
pt recvd 1 dose of vax;was tx for abdo pain & tiredness;found to have high blood pressure & sl elev ALT blood levels;pain cont;w, 2 dose of,ALT cont to rise into 200 mark;liver disease;BP remain high;w/ 3 dose ALT upper 250+;ALT down p/ 2mo
I took 1st shot about 3-4 years ago but did not get 2nd shot until last month; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (First dose received about 3-4 years ago).   In February 2022, the patient received the 2nd dose of Shingles vaccine. In February 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient inquired about shingles shot. The patient took 1st shot about 3 to 4 years ago but did not get 2nd shot until last month, which led to lengthening of vaccination schedule. The reporter stated that the pharmacist who gave the 2nd shot was uncertain if reporter needed to do another shot within next 90 days.  The reporter inquired that whether the time between shots critical.
itchy rash that comes and goes; swelling underneath the armpit; Pain; fever; Rash generalised; Hives Generalised; Eryrhema generalised; This spontaneous case was reported by a nurse and describes the occurrence of RASH PRURITIC (itchy rash that comes and goes), URTICARIA (Hives Generalised), ERYTHEMA (Eryrhema generalised), SWELLING (swelling underneath the armpit) and PAIN (Pain) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII (Yearly) and HEPATITIS B VACCIN (13 years ago). Concurrent medical conditions included Hypothyroidism since 2017 and Type 2 diabetes mellitus. Concomitant products included SEMAGLUTIDE (OZEMPIC) and LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced URTICARIA (Hives Generalised), ERYTHEMA (Eryrhema generalised) and RASH (Rash generalised). On 26-Feb-2021, the patient experienced SWELLING (swelling underneath the armpit), PAIN (Pain) and PYREXIA (fever). On 12-Mar-2021, the patient experienced RASH PRURITIC (itchy rash that comes and goes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. On 28-Feb-2021, SWELLING (swelling underneath the armpit), PAIN (Pain) and PYREXIA (fever) had resolved. On 06-Apr-2021, URTICARIA (Hives Generalised), ERYTHEMA (Eryrhema generalised) and RASH (Rash generalised) had resolved. At the time of the report, RASH PRURITIC (itchy rash that comes and goes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 101 (High) 101 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include steroid cream.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Other relevant history and lab data added, Patient details added, AE Added. Outcome of event added.
2 hours after vaccination felt flush, was pale, felt unsteady and dizzy. Developed rash down arm that burned. Took Benadryl routinely for 24 hours. Rash gone within 48 hours.
Third covid vaccine given 1/10/22 first pneumonia vaccine given 1/11/22 Patient developed fever, chills, body aches and malaise 1/12/22 He developed chest pain the night of 1/13/22 He presented to the ER with chest pain 1/14/22 and noted to have diffuse ST elevation showing pericarditis and a non-sensitive troponin of 16. He was transferred to hospital and underwent a cardiac Cath procedure
Patient got a rash on neck. Stated it has gotten worse over the past few days and is sore to the touch.
I am nursing and my son (10 months old) had a fever 10 days after my second vaccine. He also developed a rash, quarter size on his belly under his belly button about 14 days after the vaccine.  He developed this rash after the first dose as well, 10 days after I received the vaccine.
Warmth and left arm heaviness within 30 minutes. Within 24 hours, headache and nausea. Without 48 hours, severe headache, generalized muscle weakness, blurred vision, dizziness, fatigue, and chills. Mild, gradual improvement over course of 1 year, but continues to have lower extremity weakness and generalized fatigue.
Immediate swelling; rash; Pain; This non-serious case was reported by a nurse via sales rep and described the occurrence of swelling in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced swelling (Verbatim: Immediate swelling), rash (Verbatim: rash) and pain (Verbatim: Pain).  The outcome of the swelling, rash and pain were resolved.   The reporter considered the swelling, rash and pain to be related to Shingrix.     The company considered the swelling, rash and pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 05-OCT-2023 The patient received a dose of Shingrix and had immediate swelling, rash, pain lasting past 1 week. The patient sought medical care after 1 week for symptoms related to injection. The reporter consented to follow up.
After pt got several of vaccines for travel he developed that evening nightmares x 1 night & fever & chills & fatigue & "depression" until 2am 4/12/11. At 4/12/11 visit, pt says he felt normal again.
Incorrect mRNA COVID-19 vaccine product administered for second dose in 2-dose series. PT WAS SUPPOSED TO RECEIVE MODERNA AS 2ND DOSE, BUT INCORRECTLY RECEIVED PFIZER.
non-immuno suppressed father broke out in chickenpox eleven days p/ child recv vax;father visited MD who confirmed it was chicken pox & drew a varicella titer which showed the fater had had no varicella antibodies;
uncontrollable sneezing; runny nose; tired; allergies; calcium was very high; creatine high; This is a spontaneous report from a contactable consumer (patient). An 86-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: em9809) via an unspecified route of administration, administered in left arm on 08Feb2021 at 08:15 at a single dose for COVID-19 immunization.  Medical history included being deaf, glaucoma, left bundle branch block and osteoarthritis all from an unknown date and unknown if ongoing. The patient had no known allergies. The patient was not tested for COVID prior to vaccination. The patient had unspecified concomitant medications. The patient previously received the first dose of BNT162B2 (lot number: el38982) on 18Jan2021 at 08:15 AM on the left arm for COVID-19 immunization after which the patient could not hear anything. It was reported that on an unspecified date in 02Mar2021, about 2 and 1/2 weeks after receiving the second dose, the patient had uncontrollable sneezing and runny nose and was very tired. The doctor said it was allergies. The patient had a nasal swab test for COVID on 27Feb2021 and flu test on 02Mar2021 which were both negative. The patient's blood work was taken and his calcium was very high and creatine was high on 02Mar2021. The events required an emergency room visit and a physician office visit. The patient was admitted to the hospital on 02Mar2021 to Mar2021, for 5 days due to the events. They took bone biopsy and the patient was waiting for the results. It was reported that the patient was fine after the first injection and now this. The patient wanted to inform Pfizer since it may be connected. It was unknown if the patient received treatment for the events. The outcome of the events was unknown.
4/3/2019 at 12:30 pm-Patient presented to OH with complaints of redness, swelling and irritation to her right posterior arm at varicella injection site. Patient received varicella injection in OH on 4/2/2019. Area raised, small fluid-filled vesicles noted. Patient denied rash anywhere else on her body and reported a localized reaction to her right posterior arm only. Patient also reported weakness, fatigue, and feeling febrile. Temp 98.2 oral. Patient was advised that she may not work in any high-risk areas or with immunocompromised patients until the rash has resolved. Patient stated that she works in the Room and does not have direct patient contact. Patient was instructed to apply cool compresses to the area several times a day, take MOTRIN OTC or other anti-inflammatory medication as directed, and take BENADRYL PRN for itching. Patient was also instructed to follow-up with OH in the morning for re-evaluation of rash/localized reaction. Patient verbalized understanding and denied further questions or concerns at this time. RN. 4/4/2019 at 7 am-Patient presented to OH for re-evaluation of varicella vaccine injection site. Increased redness and swelling noted with large fluid-filled blisters present at injection site. Redness and swelling now extends around the posterior to arm to the right medial and lateral arm. Patient complained of increased pain and generalized feelings of fatigue and malaise. Patient was referred to Clinic for evaluation per an OH medical provider, location chosen per Patient's preference. Patient was instructed to follow-up with OH after her evaluation at Clinic. Patient verbalized understanding and denied further questions or concerns at this time. RN.
Red raised lesion that has continued to expand on right deltoid that is now as big as a baseball. Warm to the touch. Pt complains of fever and malaise. Lower than normal blood pressure. Soreness but no known decrease in arm mobility. Because of the presentation of adverse effect and continued expansion along with patient reported fever, the patient was referred to a walk in clinic to be evaluated.
Red, itchy bumps across arms & chest - progressed across face & legs, facial swelling.
Local Right - swelling redness- covering entire upper arm. Area marked with pen. If redness spreads start antibiotic.